chr13-43904864-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000627615.1(ENSG00000281883):n.*285-2016A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 152,210 control chromosomes in the GnomAD database, including 1,263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain risk allele (no stars).
Frequency
Genomes: 𝑓 0.12 ( 1263 hom., cov: 32)
Consequence
ENSG00000281883
ENST00000627615.1 intron
ENST00000627615.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.503
Publications
12 publications found
Genes affected
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.272 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENSG00000281883 | ENST00000627615.1 | n.*285-2016A>G | intron_variant | Intron 4 of 12 | 5 | ENSP00000486083.1 |
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18077AN: 152092Hom.: 1251 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18077
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.119 AC: 18109AN: 152210Hom.: 1263 Cov.: 32 AF XY: 0.126 AC XY: 9410AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
18109
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
9410
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
3588
AN:
41574
American (AMR)
AF:
AC:
1932
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
466
AN:
3470
East Asian (EAS)
AF:
AC:
1470
AN:
5180
South Asian (SAS)
AF:
AC:
1185
AN:
4812
European-Finnish (FIN)
AF:
AC:
1839
AN:
10596
Middle Eastern (MID)
AF:
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7138
AN:
67962
Other (OTH)
AF:
AC:
275
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
796
1591
2387
3182
3978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1147
AN:
3478
ClinVar
Significance: Uncertain risk allele
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Leprosy, susceptibility to, 1 Other:1
Jun 10, 2022
Centro Dermatológico Federico Lleras Acosta, Hospital Universitario Centro Dermatológico Federico Lleras Acosta
Significance:Uncertain risk allele
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.